Ask Warren

ST Pharm

237690 · KOSDAQ · ₩237690 · 에스티팜

₩72,500▼ ₩1,500 (2.03%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Revenue₩108B₩67B₩129B₩82B₩68B₩52B₩116B₩62B
Cost of sales₩69B₩36B₩81B₩45B₩36B₩33B₩76B₩39B
Gross profit₩39B₩31B₩48B₩37B₩32B₩19B₩39B₩22B
Operating income₩18B₩12B₩26B₩15B₩13B₩1B₩23B₩6.1B
Net income₩13B₩15B₩31B₩17B₩5.4B₩709M₩12B₩14B
Net income to shareholders₩13B₩15B₩31B₩18B₩5.4B₩1B₩13B₩15B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Total assets₩848B₩850B₩783B₩755B₩732B₩742B₩722B₩692B
Current assets₩447B₩445B₩373B₩357B₩322B₩337B₩330B₩323B
Cash and equivalents₩54B₩111B₩31B₩44B₩42B₩25B₩63B₩41B
Total liabilities₩219B₩239B₩190B₩200B₩232B₩248B₩219B₩203B
Current liabilities₩196B₩214B₩165B₩175B₩148B₩162B₩133B₩81B
Borrowings₩73B₩72B₩77B₩77B₩115B₩115B₩115B₩119B
Total equity₩629B₩611B₩593B₩556B₩500B₩494B₩503B₩489B
Shareholders' equity₩629B₩612B₩593B₩557B₩501B₩495B₩503B₩488B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
Cash from operations₩1.5B₩103B−₩21B₩29B−₩11B₩17B₩56B₩9B
Capital spending₩6B₩9B₩5.7B₩15B₩6B₩21B₩35B₩17B
Free cash flow−₩4.6B₩94B−₩27B₩15B−₩17B−₩3.4B₩21B−₩8.4B
Dividends paid₩0₩10B₩0₩0₩0₩10B₩0₩0

Consolidated where available. Amounts in won.

Also known as: ST Pharm / 에스티팜 / 237690 / KRX:237690

Source: KRX statistical information